Table 4. Univariate and multivariate Cox regression analyses of predictors of overall survival.
| Variable | R | Cl (95%) | P |
|---|---|---|---|
| Univariate analysis (n = 233) | |||
| Age | 2.200 | 1.325–3.652 | 0.002 |
| Gender | 0.641 | 0.351–1.172 | 0.149 |
| T stage (T1–2/T3–4) | 2.300 | 1.355–3.903 | 0.002 |
| N stage (N0/N1–3) | 2.414 | 1.267–4.601 | 0.007 |
| Clinical stage (I–II/III–IV) | 2.958 | 1.512–5.786 | 0.002 |
| Lox (low/high) | 1.825 | 1.138–2.927 | 0.013 |
| WHO histological classification | 1.075 | 0.643–1.797 | 0.784 |
| Multivariate analysis (n = 233) | |||
| Age | 2.115 | 1.271–3.519 | 0.004 |
| Clinical stage (I–II/III–IV) | 1.783 | 1.108–2.868 | 0.017 |
| Lox (low/high) | 3.159 | 1.612–6.191 | 0.001 |
HR, hazard ratio; 95% CI, 95% confidence interval; LOX, lysyl oxidase.